KRISTI KROENLEIN: Open Payments
NPI 1619963881 · PEKIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 51 payments from 17 companies in 2025. Trend: 2023 $853 · 2024 $926 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 14 | $153 |
| ABBVIE INC. | 8 | $143 |
| PFIZER INC. | 5 | $93 |
| Astellas Pharma US Inc | 4 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $27 |
Products named: ZENPEP, NURTEC ODT, Veozah, VRAYLAR, CAPLYTA, UBRELVY, MYFEMBREE, Mirena.
Industry payments across IL — which companies pay providers there.
